Antibody Affinity Maturation to SARS-CoV-2 Omicron Variants in a Teachers Cohort
James-Pemberton, P. H.; Kohli, S.; Westlake, A.; Antill, A.; Olkhov, R.; Shaw, A.
Show abstract
Prevalence of SARS-CoV-2 amongst school children in the omicron wave was high leading to a constant exposure of teachers to the virus. A cohort of staff members (n = 28) was recruited from a UK primary school setting. The prevalent variants at the time were Omicron BA.1, BA.4/5 and BA.2: 61% of the cohort reported a lateral-flow-confirmed positive test for SARS-CoV-2 infection in late 2021 or 2022. A mass-standardised quantitative antibody spectrum was measured for both antibody concentration and a new measure of antibody quality; the proportion of antibodies still bound to the epitope at pH 3.2 compared with pH 7.4. The antibody spectrum was measured or IgG to the spike protein for variants Wuhan, Alpha, Beta, Gamma, Delta and Omicron BA.1, BA.2.75, BA.2.12.1, BA.4 and BA.5. The new antibody quality measure shows a mean of 49% with (IQR 32% - 68%). The cohort showed a Universal positive immunity endotype, U(+), of antibodies binding to the spike protein across the variant spectrum with an incidence of 78% (95% CI 60% - 88%) with good antibody concentrations to all ten variants; the incidence drops to 25% (95% CI 13% - 43%) when the affinity spectrum is measured.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration 94%
- Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation 93%
- Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assay 93%
Similar papers in this journal
- The antibody response to SARS-CoV-2 increases over 5 months in patients with anosmia/dysgeusia 93%
- Wearable Sensor and Digital Twin Technology for the Development of a Personalized Digital Biomarker of Vaccine-Induced Inflammation 92%
- A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms 91%
Similar papers in this journal
- SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface 94%
- Tiger team: a panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes 93%
- Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray 93%
Similar papers in this journal
- Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 disease 94%
- Serum Antibody Fingerprinting for SARS-CoV-2 Variants in Infected and Vaccinated Subjects by Label-Free Microarray Biosensor 94%
- Novel ELISA protocol links pre-existing SARS-CoV-2 reactive antibodies with endemic coronavirus immunity and age and reveals improved serologic identification of acute COVID-19 via multi-parameter detection 93%
Similar papers in this journal
- A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2 97%
- Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2 92%
- Follow-up study in the ski-resort Ischgl: Antibody and T cell responses to SARS-CoV-2 persisted for up to 8 months after infection and transmission of virus was low even during the second infection wave in Austria 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.